Lupus & antiphospholipid syndrome

Glycosylation of anti-double-stranded DNA (anti-dsDNA) immunoglobulin G (IgG) correlates with organ involvement in treatment-naïve patients with systemic lupus erythematosus

Lupus Sci MedPublished Cross-sectional study

Authors' conclusion

Our study showed the effectiveness of combining glycoforms to classify and predict the degree of SLE organ involvement.

Study context

Population
Consecutive treatment-naïve patients with SLE positive for anti-dsDNA antibodies, Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai, 2017–2019
Participants
86 patients
Outcome
Correlation between anti-dsDNA IgG glycoform pair levels and degree of organ involvement
Methodological detailsconsecutive enrolment, single-centre, machine learning (random forest classifier, artificial neural network)
  • Consecutive enrolment
  • Single-centre
  • Machine learning (random forest classifier, artificial neural network)

Main finding

As reported in the abstract

Classification and prediction of degree of SLE organ involvement by anti-dsDNA IgG glycoforms

Random forest: IgG1Gal + IgG3/4Bis combination, highest accuracy

0.7692

Random forest: IgG1Gal + IgG3/4Bis combination, highest AUC

0.8187

Artificial neural network: IgG3/4Bis and IgG1Gal, lowest mean squared error

0.0244

Observational data: associations, not effects.

Further findings

Correlation between involved and uninvolved organs (Pearson)

Strong connection between involved and uninvolved organs

Original publication

Glycosylation of anti-dsDNA IgG correlates with organ involvement in treatment-naïve patients with systemic lupus erythematosus. Lupus Sci Med. Published 1 September 2025. doi:10.1136/lupus-2025-001665

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.